• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎病毒感染中肠道微生物群的改变与丙氨酸氨基转移酶水平的关系

Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level.

作者信息

Yun Yeojun, Chang Yoosoo, Kim Han-Na, Ryu Seungho, Kwon Min-Jung, Cho Yong Kyun, Kim Hyung-Lae, Cheong Hae Suk, Joo Eun-Jeong

机构信息

Gwanghwamun Medical Study Centre, Syntekabio Inc., Seoul 03186, Korea.

Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 04514, Korea.

出版信息

J Clin Med. 2019 Feb 2;8(2):173. doi: 10.3390/jcm8020173.

DOI:10.3390/jcm8020173
PMID:30717396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407135/
Abstract

The changes in the gut microbiota of healthy hepatitis B virus (HBV) carriers, including asymptomatic and non-cirrhotic subjects, have been rarely scrutinized. From 1463 faecal samples in health examinees, in total 112 subjects, including 36 hepatitis B surface antigen (HBsAg)-positive and 76 control subjects, were included. Twenty-eight of 36 HBsAg-positive individuals (78%) showed normal alanine aminotransferase (ALT) levels (normal ALT group), whereas eight subjects exhibited elevated ALT levels (22%, high ALT group). By using 16S rRNA gene sequencing, the distance between normal and high ALT groups among HBsAg-positive subjects showed a significant separation after the pairwise comparison of weighted UniFrac distance (permutational analysis of variance -value = 0.039), when compared with the distances to the control group. In comparison with the control group, the normal ALT group had as a significant taxon that showed a positive association (Coefficient () = 0.028, = 0.039). ( = 0.54, = 0.014) and ( = 1.41, = 0.030) showed positive correlations, and ( = -1.31, = 4.15 × 10) exhibited a negative correlation with high ALT level. Gut microbial composition was different according to HBV-induced serum ALT levels, indicative of a potential link between gut and liver metabolism.

摘要

健康乙肝病毒(HBV)携带者,包括无症状和非肝硬化患者,其肠道微生物群的变化很少受到仔细研究。在1463份健康体检者的粪便样本中,共纳入了112名受试者,其中包括36名乙肝表面抗原(HBsAg)阳性者和76名对照受试者。36名HBsAg阳性个体中有28名(78%)丙氨酸转氨酶(ALT)水平正常(正常ALT组),而8名受试者ALT水平升高(22%,高ALT组)。通过16S rRNA基因测序,与对照组的距离相比,HBsAg阳性受试者中正常ALT组和高ALT组之间的加权UniFrac距离经成对比较后显示出显著分离(方差置换分析 -值 = 0.039)。与对照组相比,正常ALT组有 作为一个显著的分类群呈现正相关(系数() = 0.028, = 0.039)。 ( = 0.54, = 0.014)和 ( = 1.41, = 0.030)与高ALT水平呈正相关,而 ( = -1.31, = 4.15 × 10)与高ALT水平呈负相关。肠道微生物组成因HBV诱导的血清ALT水平而异,表明肠道与肝脏代谢之间存在潜在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/d410ea877dcf/jcm-08-00173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/d0b049b7a044/jcm-08-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/e504ab3f15c2/jcm-08-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/27867332b140/jcm-08-00173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/d410ea877dcf/jcm-08-00173-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/d0b049b7a044/jcm-08-00173-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/e504ab3f15c2/jcm-08-00173-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/27867332b140/jcm-08-00173-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717a/6407135/d410ea877dcf/jcm-08-00173-g004.jpg

相似文献

1
Alterations of the Gut Microbiome in Chronic Hepatitis B Virus Infection Associated with Alanine Aminotransferase Level.慢性乙型肝炎病毒感染中肠道微生物群的改变与丙氨酸氨基转移酶水平的关系
J Clin Med. 2019 Feb 2;8(2):173. doi: 10.3390/jcm8020173.
2
[The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers].[非活动性HBsAg携带者血清转氨酶水平的随访及乙肝病毒载量的调查]
Mikrobiyol Bul. 2007 Jul;41(3):429-33.
3
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.使用 HBsAg 和 HBV-DNA 的基线血清学测量预测无症状乙型肝炎 e 抗原阴性慢性乙型肝炎患者的疾病再激活。
J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.
4
[Clinical significance of serum HBsAg levels, HBsAg/HBV DNA ratio, and association with liver inflammation activity in HBeAg-positive chronic hepatitis B].[HBeAg阳性慢性乙型肝炎患者血清HBsAg水平、HBsAg/HBV DNA比值及其与肝脏炎症活动度的相关性的临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2015 Jan;23(1):40-5. doi: 10.3760/cma.j.issn.1007-3418.2015.01.010.
5
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.慢性乙型肝炎患儿血清乙型肝炎表面抗原和乙型肝炎e抗原定量水平的重要性。
Turk J Gastroenterol. 2015 Jan;26(1):36-41. doi: 10.5152/tjg.2015.4636.
6
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.乙肝e抗原阴性乙肝表面抗原携带者的长期预后与丙氨酸氨基转移酶水平随时间的变化关系
Hepatology. 2009 Jun;49(6):1859-67. doi: 10.1002/hep.22878.
7
HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers.乙肝表面抗原阳性慢性携带者的乙肝e抗原/乙肝e抗体、丙氨酸转氨酶及乙肝病毒DNA水平
Bangladesh Med Res Counc Bull. 2008 Aug;34(2):39-43. doi: 10.3329/bmrcb.v34i2.1173.
8
Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels.慢性乙型肝炎e抗原阳性、丙氨酸氨基转移酶水平正常或轻度升高患者肝脏组织学变化及对聚乙二醇干扰素持续病毒学应答的预测因素
J Viral Hepat. 2017 Jul;24(7):573-579. doi: 10.1111/jvh.12679. Epub 2017 Feb 16.
9
[Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].[肝脂肪变性:HBV DNA载量低的HBsAg阳性慢性乙型肝炎患者丙氨酸氨基转移酶水平升高的常见原因]
Zhonghua Gan Zang Bing Za Zhi. 2008 Nov;16(11):818-22.
10
Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up.多次检测乙肝表面抗原可在长期随访中识别出非活动期 HBV 携带者。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1481-1489.e5. doi: 10.1016/j.cgh.2016.01.019. Epub 2016 Feb 10.

引用本文的文献

1
Gut microbiota links to histological damage in chronic HBV infection patients and aggravates fibrosis via fecal microbiota transplantation in mice.肠道微生物群与慢性乙型肝炎病毒感染患者的组织学损伤相关,并通过小鼠粪便微生物群移植加重纤维化。
Microbiol Spectr. 2025 Aug 5;13(8):e0076425. doi: 10.1128/spectrum.00764-25. Epub 2025 Jul 11.
2
Gut Microbiota and the Gut-Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies.肠道微生物群与肝脏疾病中的肠-肝轴:从慢性病毒性肝炎到肝硬化、肝细胞癌及基于微生物群的治疗方法
Microorganisms. 2025 Apr 30;13(5):1053. doi: 10.3390/microorganisms13051053.
3

本文引用的文献

1
Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.肠道微生物群失调与慢性乙型肝炎患者肝功能和血清代谢物改变有关。
Front Microbiol. 2017 Nov 13;8:2222. doi: 10.3389/fmicb.2017.02222. eCollection 2017.
2
Current status and strategies for hepatitis B control in Korea.韩国乙型肝炎防治的现状与策略。
Clin Mol Hepatol. 2017 Sep;23(3):205-211. doi: 10.3350/cmh.2017.0104. Epub 2017 Sep 19.
3
Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort.
Delites™ supplementation prevents metabolic syndrome onset and modulates gut microbiome in male Sprague Dawley rats fed on cholesterol- and fat-enriched diet: a randomized preclinical trial study.
Delites™补充剂可预防食用富含胆固醇和脂肪饮食的雄性斯普拉格-道利大鼠发生代谢综合征并调节肠道微生物群:一项随机临床前试验研究。
Front Nutr. 2025 Apr 22;12:1571473. doi: 10.3389/fnut.2025.1571473. eCollection 2025.
4
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis.机器学习算法揭示了与慢性乙型肝炎相关肝纤维化相关的肠道微生物群特征。
World J Gastroenterol. 2025 Apr 28;31(16):105985. doi: 10.3748/wjg.v31.i16.105985.
5
Gut microbiota shifts in hepatitis B-related portal hypertension after transjugular intrahepatic portosystemic shunt: Mechanistic and clinical implications.经颈静脉肝内门体分流术后乙肝相关性门静脉高压症患者肠道微生物群的变化:机制及临床意义
World J Gastroenterol. 2025 Jan 21;31(3):100752. doi: 10.3748/wjg.v31.i3.100752.
6
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.肝细胞癌发生过程中病因依赖的微生物组差异
Int J Mol Sci. 2024 Dec 17;25(24):13510. doi: 10.3390/ijms252413510.
7
Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study.肠道微生物群作为乙型肝炎病毒与肝细胞癌之间的介导者和调节者:一项前瞻性研究
Cancer Med. 2024 Dec;13(24):e70454. doi: 10.1002/cam4.70454.
8
Role of tenofovir dipivoxil in gut microbiota recovery from HBV-infection induced dysbiosis.替诺福韦酯在乙型肝炎病毒感染诱导的肠道菌群失调恢复中的作用。
BMC Microbiol. 2024 Sep 20;24(1):359. doi: 10.1186/s12866-024-03457-4.
9
Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension.经颈静脉肝内门体分流术治疗乙型肝炎相关门静脉高压症患者的肠道微生物组改变。
World J Gastroenterol. 2024 Aug 21;30(31):3668-3679. doi: 10.3748/wjg.v30.i31.3668.
10
The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status.COVID-19 患者炎症、脂类衍生物与肠道菌群代谢物之间的关联:对饮食行为和营养状况的影响。
Int J Mol Sci. 2024 Jul 19;25(14):7899. doi: 10.3390/ijms25147899.
一项大型韩国队列中与体重指数相关的肠道微生物群的比较分析。
BMC Microbiol. 2017 Jul 4;17(1):151. doi: 10.1186/s12866-017-1052-0.
4
Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.乙型肝炎病毒感染与非酒精性脂肪性肝病风险降低的相关性:一项队列研究。
Hepatology. 2017 Mar;65(3):828-835. doi: 10.1002/hep.28917. Epub 2016 Dec 30.
5
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.代谢健康型肥胖与非酒精性脂肪性肝病的发生发展
Am J Gastroenterol. 2016 Aug;111(8):1133-40. doi: 10.1038/ajg.2016.178. Epub 2016 May 17.
6
Relationship between chronic hepatitis B and metabolic syndrome: A structural equation modeling approach.慢性乙型肝炎与代谢综合征之间的关系:一种结构方程建模方法。
Obesity (Silver Spring). 2016 Feb;24(2):483-9. doi: 10.1002/oby.21333. Epub 2015 Dec 31.
7
A gut-vascular barrier controls the systemic dissemination of bacteria.肠道-血管屏障控制细菌的全身传播。
Science. 2015 Nov 13;350(6262):830-4. doi: 10.1126/science.aad0135.
8
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.《亚太地区乙型肝炎管理临床实践指南:2015年更新版》
Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13.
9
Decompensated cirrhosis and microbiome interpretation.失代偿期肝硬化与微生物组解读。
Nature. 2015 Sep 17;525(7569):E1-2. doi: 10.1038/nature14851.
10
Gut microbiota modulate the immune effect against hepatitis B virus infection.肠道微生物群调节针对乙型肝炎病毒感染的免疫效应。
Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2139-47. doi: 10.1007/s10096-015-2464-0. Epub 2015 Aug 14.